Paper Review Records
All Paper Review Records
10 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
67
days
Implementation of a gynecologic oncology ultrasound training program to support cervical cancer staging at Queen Elizabeth Central Hospital in Malawi
AuthorsGeorge Kassim Chilinda; Samuel James Meja; Roman Kocián; Mariateresa Mirandola; Yacinta Pindulani; Sylvie Goossens; Victor Mwapasa; Inne H.M. Borel Rinkes; Denis Querleu; Pierre-Francois Dupre; Marcus J. Rijken
AffiliationsQueen Elizabeth Central Hospital, Gynaecological Oncology Unit, Department of Obstetrics & Gynaecology, Blantyre, Malawi; Kamuzu University of Health Sciences, School of Public Health, Department of Health Systems and Policy, Blantyre, Malawi; Kamuzu University of Health Sciences, School of Medicine, Department of Obstetrics and Gynaecology, Blantyre, Malawi; Charles University and General University Hospital in Prague, First Faculty of Medicine, Gynaecologic Oncology Centre, Department of Gynaecology, Obstetrics and Neonatology, Prague, Czech Republic; IRCCS, Fondazione Policlinico Universitario Agostino Gemelli, Dipartimento Scienze della Salute della Donna del Bambino e di Sanità Pubblica, Rome, Italy; Università Cattolica del Sacro Cuore, Dipartimento Universitario di Scienze della Vita e Sanità Pubblica, Roma, Italia; Netherlands Cancer Institute-Antoni van Leeuwenhoek, Centre of Gynaecologic Oncology, Department of Gynaecologic Oncology, Amsterdam, The Netherlands; Utrecht University, University Medical Centre Utrecht, Julius Centre for Health Science and Primary Care, Julius Global Health, Utrecht, The Netherlands; Utrecht University, University Medical Centre, Department of Oncology, Utrecht, The Netherlands; Université de Brest, Institut de Cancérologie et Hématologie, Service de Gynécologie-Obstétrique et Médecine de la Reproduction, Brest, France; Médecins Sans Frontières -Operation Centre Paris-Malawi mission, Blantyre Cervical Cancer project, Blantyre, Malawi; Médecins Sans Frontières – Operational Centre Paris, Paris, France
52
days
Cervical cancer screening among transgender and gender diverse individuals: a systematic review and meta-analysis
AuthorsAmelia Srajer; John M. Hutchinson; Amy Metcalfe; Darren R. Brenner; Kristin A. Black; Fiona Mattatall; Ioana Nicolau; Paul E. Ronksley
AffiliationsUniversity of Calgary, Cumming School of Medicine, Department of Community Health Sciences, Calgary, AB, Canada; University of Calgary, Cumming School of Medicine, Department of Obstetrics and Gynecology, Calgary, AB, Canada; University of Calgary, Cumming School of Medicine, Department of Oncology, Calgary, AB, Canada; University of Calgary, Cumming School of Medicine, Department of Medicine, Calgary, AB, Canada; Cancer Care Alberta, Department of Cancer Epidemiology and Prevention Research, Calgary, AB, Canada
96
days
Fertility-sparing surgery in patients with advanced borderline ovarian tumors
AuthorsTommaso Bianchi; Marta Jaconi; Elena De Ponti; Tommaso Grassi; Martina Bombelli; Giorgia Pecis Cavagna; Marta Seca; Jasmine Corti; Alessandra Inzoli; Daniela Giuliani; Gaetano Trezzi; Alessandra Casiraghi; Laura Russo; Stefania Chiari; Andrea Alberto Lissoni; Robert Fruscio
AffiliationsFondazione IRCCS San Gerardo dei Tintori, Division of Gynecology, Monza, Italy; Fondazione IRCCS San Gerardo dei Tintori, Division of Pathology, Monza, Italy; Fondazione IRCCS San Gerardo dei Tintori, Division of Medical Physics, Monza, Italy; University of Milano-Bicocca, Department of Medicine and Surgery, Milano, Italy; Fondazione IRCCS San Gerardo dei Tintori, Division of Radiology, Monza, Italy
132
days
Does the prophylactic use of compression garments reduce the risk of lower limb lymphedema after pelvic and/or inguinal lymphadenectomy for gynecological cancer? A systematic review
AuthorsStefano Gentileschi; Giorgia Garganese; Simona Maria Fragomeni; Luca Tagliaferri; Anna Fagotti; Anna Amelia Caretto
AffiliationsUniversità Cattolica del Sacro Cuore, Dipartimento di Medicina e Chirurgia Traslazionale, Roma, Italia; Fondazione Policlinico Universitario A. Gemelli IRCCS, Dipartimento Scienze Della Salute Della Donna E Del Bambino E Di Sanità Pubblica, Unità di Chirurgia Plastica, Roma, Italia; Fondazione Policlinico Universitario A. Gemelli IRCCS, Dipartimento Scienze della Salute della Donna, del Bambino e di Sanità Pubblica, Unità Ginecologia Oncologica, Roma, Italia; Università Cattolica del Sacro Cuore, Dipartimento di Scienze della Vita e Sanità Pubblica, Roma, Italia; Fondazione Policlinico Universitario A. Gemelli IRCCS, Dipartimento Diagnostica per Immagini Radioterapia Oncologica ed Ematologia, Roma, Italia
60
days
External Validation of the IOTA Two-Step Strategy for Pre-operative Characterization of Adnexal Masses: Comparison with ADNEX, O-RADS and a Sequential Simple Rules–ADNEX Approach
AuthorsMatteo Marchetti; Giulia Spagnol; Eleonora Panizzolo; Massimo Carollo; Tommaso Vezzaro; Jacopo Ferrari; Chiara Vio; Chiara Munerol; Roberto Tozzi; Marco Noventa
AffiliationsUniversity of Padua, Department of Gynecology and Obstetrics, Division of Women’s and Children's Health, Padova, Italy; University of Verona, Department of Diagnostics and Public Health, Verona, Italy; ULSS 1 Dolomiti, Department of Primary Care, Belluno, Italy; Local Health Unit Marca Trevigiana, Ospedale Ca' Foncello, Treviso, Italy
80
days
Post-operative venous thromboembolism in advanced epithelial ovarian cancer: risk factors, tumor gene expression, and survival
AuthorsMatilda Salko; Lasse Myllylahti; Sara Palomino-Echeverria; Johanna Tapper; Riitta Koivisto-Korander; Anna Kanerva; Kaisa Nelskylä; Mikko Loukovaara; Anniina Färkkilä; Ulla-Maija Haltia; Riitta Lassila
AffiliationsUniversity of Helsinki, Faculty of Medicine, Research Program in Systems Oncology, Helsinki, Finland; Helsinki University Hospital, Comprehensive Cancer Center, Department of Hematology, Helsinki, Finland; University of Helsinki, Faculty of Medicine, Research Program in Systems Oncology, Coagulation Disorders, Helsinki, Finland; University of Helsinki, Helsinki Institute of Life Sciences, Institute for Molecular Medicine Finland, Helsinki, Finland; Helsinki University Hospital, Department of Obstetrics and Gynecology, Helsinki, Finland; Helsinki University Hospital, Women’s Hospital, Department of Anesthesiology, Perioperative and Intensive Care, Helsinki, Finland; iCAN Digital Precision Cancer Medicine Flagship, Helsinki, Finland
128
days
Patient preferences for sexual health counseling across the Gynecologic Cancer Care Continuum: the sexual health integration in treatment of gynecological oncology (SHIFT-GO Study)
AuthorsKrzysztof Nowosielski; Joanna Kacperczyk-Bartnik; Magdalena Bizoń
AffiliationsMedical University of Silesia, University Clinical Center, Department of Gynecology, Obstetrics and Gynecological Oncology, Katowice, Poland; Medical University of Warsaw, 2nd Department of Obstetrics and Gynecology, Warsaw, Poland; Maria Skłodowska-Curie National Research Institute of Oncology, Gynecologic Oncology Department, Warsaw, Poland; LUX MED Oncology Hospital, Department of Gynecological Oncology, Warsaw, Poland; Center of Oncology, Department of Gynecological Oncology, Bielsko-Biala, Poland
95
days
Intermittent olaparib with neoadjuvant platinum-based chemotherapy in BRCA-mutated un-resectable ovarian cancer: the NUVOLA trial
AuthorsVanda Salutari; Claudia Marchetti; Elena Giudice; Camilla Nero; Diana Giannarelli; Viola Ghizzoni; Sara Lardino; Carolina Maria Sassu; Barbara Costantini; Giulia Ponti; Gian Franco Zannoni; Giovanni Scambia; Anna Fagotti
AffiliationsFondazione Policlinico Universitario A. Gemelli IRCCS, Department of Woman, Child and Public Health, Rome, Italy; Università Cattolica del Sacro Cuore, Institute of Obstetrics and Gynecology, Rome, Italy
84
days
Differences in first-line chemosensitivity assessed by ELIMination rate constant K in advanced serous ovarian cancer: evidence from Western and Japanese Trials in a Gynecologic Cancer InterGroup meta-analysis
AuthorsPauline Corbaux; Benoit You; Iain McNeish; Stephen Welch; Anna V. Tinker; Mansoor R. Mirza; Kristina Lindemann; Tatsuo Kagimura; Isabelle L. Ray-Coquard; Fabien Subtil; Julien Péron; Karen Carty; Caroline Kelly; Olivier Colomban; Eleni Karamouza; Adrian Cook; Xavier Paoletti; Rosalind M. Glasspool; Nozomu Yanaihara
AffiliationsClaude Bernard University Lyon 1, Faculty of Medicine Lyon-Sud, Centre pour l'lnnovation en Cancérologie de Lyon (CICLY), Lyon, France; GINECO, CHU de Saint-Etienne, Institut de Cancérologie et d’Hématologie Universitaire de Saint-Etienne, Medical Oncology, Saint-Etienne, France; GINEGEPS, GINECO, Centre Hospitalier Lyon-Sud, CITOHL, Institut de Cancérologie des Hospices Civils de Lyon (IC-HCL), Medical Oncology, Lyon, France; Imperial College London, Department of Surgery and Cancer, London, United Kingdom; London Health Sciences Centre, London, ON, Canada; BC Cancer – Vancouver, Vancouver, BC, Canada; Nordic Society of Gynecological Oncology, Copenhagen, Denmark; Copenhagen University Hospital, Rigshospitalet, Department of Oncology, Copenhagen, Denmark; Norwegian Radium Hospital, Oslo, Norway; Translational Research Center for Medical Innovation, Foundation for Biomedical Research and Innovation at Kobe, Kobe, Japan; Inserm U1290 Claude Bernard University Lyon 1 GINECO, Centre Léon Bérard, Lyon, France; Hospices Civils de Lyon, Service de Biostatistique, Lyon, France; Université Claude Bernard Lyon 1, LBBE, UMR 5558, CNRS, VAS, Villeurbanne, France; University of Glasgow, Institute of Cancer Sciences, Glasgow Oncology Clinical Trials Unit, Glasgow, United Kingdom; Université Paris-Saclay, Office of Biostatistics and Epidemiology, Institut Gustave Roussy, Villejuif, France; Inserm, Université Paris-Saclay, CESP U1018, Oncostat, labeled Ligue Contre le Cancer, Villejuif, France; MRC Clinical Trials Unit at UCL, London, United Kingdom; Institut Curie, St Cloud, France; Beatson West of Scotland Cancer Centre, NHS Greater Glasgow and Clyde, Glasgow, United Kingdom; University of Glasgow, School of Cancer Sciences, Glasgow, United Kingdom; The Jikei University School of Medicine, Tokyo, Japan
109
days
Quality of life and patient-reported outcomes after non-surgical management of early-stage endometrial cancer and endometrial hyperplasia with atypia: a long-term follow-up of the feMMe phase II randomized clinical trial
AuthorsKatharina Steger; Eva Baxter; Ruqaiya Al Ramadhani; Monika Janda; Andreas Obermair
AffiliationsThe University of Queensland, Queensland Centre for Gynaecological Cancer Research, Brisbane, QLD, Australia; Medical University of Innsbruck, Department of Obstetrics and Gynecology, Innsbruck, Austria; The University of Queensland, Faculty of Health, Medicine and Behavioral Sciences, Centre for Health Services Research, Brisbane, QLD, Australia
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
Client
I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?
CrushSCI
Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.
- Suggested title
- Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment
- Database shortlist
- Environmental Technology & Innovation
SampleLatest 5 valid paper samples from 2026
Average review96.4 days
Median77 days